A detailed history of Farther Finance Advisors, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 15 shares of PTCT stock, worth $678. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 5 200.0%
Holding current value
$678
Previous $156,000 257.05%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$30.39 - $37.66 $303 - $376
10 Added 200.0%
15 $557,000
Q2 2024

Jul 31, 2024

BUY
$24.69 - $40.12 $74 - $120
3 Added 150.0%
5 $156,000
Q1 2024

May 13, 2024

SELL
$24.15 - $31.95 $24 - $31
-1 Reduced 33.33%
2 $57,000
Q4 2023

Feb 14, 2024

SELL
$18.07 - $29.37 $18 - $29
-1 Reduced 33.33%
2 $55,000
Q1 2023

May 13, 2024

BUY
$38.16 - $48.86 $38 - $48
1 Added 50.0%
3 $145,000
Q4 2022

Sep 11, 2023

BUY
$33.53 - $54.79 $100 - $164
3 New
3 $115,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.24B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.